who created semaglutide The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor) Semaglutide | Description, Uses, &

Weight Regain Patterns After Discontinuing GLP-1 Therapy Clinical data shows that patients who stop semaglutide without lifestyle intervention regain approximately 50% of lost weight within 6-12 months

Boost Metabolism and Burn More Powered by GBBGO, a next-gen super carnitine that naturally ramps up your bodys own L-Carnitine productionhelping you convert fat into energy more efficiently while supporting increased natural energy

We highly recommend him!

Tirzepatide Ozempic (semaglutide) isnt the only GLP-1 receptor agonist

When combined with medications such as sodium-glucose cotransporter-2 (SGLT-2) inhibitors or specific insulin formulations that exhibit complementary effects on weight regulation, combination therapy has the potential to significantly enhance weight loss outcomes and improve body composition in patients with co-morbid type 2 diabetes and obesity

A related formulation, Wegovy (also semaglutide but at higher doses), has been licensed specifically for weight management in adults with obesity (NICE TA875)